2023
DOI: 10.1016/j.isci.2023.106076
|View full text |Cite
|
Sign up to set email alerts
|

Myeloid-cell-specific role of Gasdermin D in promoting lung cancer progression in mice

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…The other players in the inflammasome pathway such as Gasdermin-D are is also involved in the macrophage inflammasome-dependent proliferation of cancer where lung metastasis in Gasdermin D -/- mice was reduced ( 30 ). Similar to our study, macrophage gasdermin-D plays a role in the tumor microenvironment.…”
Section: Discussionmentioning
confidence: 99%
“…The other players in the inflammasome pathway such as Gasdermin-D are is also involved in the macrophage inflammasome-dependent proliferation of cancer where lung metastasis in Gasdermin D -/- mice was reduced ( 30 ). Similar to our study, macrophage gasdermin-D plays a role in the tumor microenvironment.…”
Section: Discussionmentioning
confidence: 99%
“…Further, GSDMD was required for the infiltration of CD8 + T cells into the tumor microenvironment (TME) of NSCLC to ensure an immune response, whereas GSDMD deficiency increased the cytolytic capacity of CD8 + T cells ( 53 ). GSDMD knockout markedly decreased lung cancer metastasis in a metastatic lung carcinoma cell model ( 54 ). Chen et al ( 19 ) reported that in NSCLC cell lines, GSDMD knockdown promoted caspase-3-induced apoptosis independent of other apoptotic stimuli, and GSDMD suppression inhibited tumor growth in a mouse model.…”
Section: Gsdmdmentioning
confidence: 99%
“…Studies have shown that GSDMD deletion or inhibition notably decreases pyroptosis and remarkably protect mice from sepsis, which is a fatal condition requiring urgent medical solutions ( 12 14 ). In addition, GSDMD acts as an effector of inflammasome signaling and is implicated in several human diseases, including nonalcoholic steatohepatitis ( 15 ), cardiovascular disease ( 16 ), inflammatory bowel disease ( 17 ), type II diabetes ( 17 , 18 ), rheumatoid arthritis ( 19 ), cancer ( 20 , 21 ), and Alzheimer’s disease ( 22 ). Consequently, on account of the crucial function of GSDMD in pyroptosis, it has emerged as an ideal and attracting target for therapeutic intervention of inflammasome-driven diseases.…”
Section: Introductionmentioning
confidence: 99%